146 related articles for article (PubMed ID: 14293024)
1. 6-DIAZO-5-OXO-L-NORLEUCINE INHIBITION OF ESCHERICHIA COLI.
COGGIN JH; MARTIN WR
J Bacteriol; 1965 May; 89(5):1348-53. PubMed ID: 14293024
[TBL] [Abstract][Full Text] [Related]
2. Modulation of heparan sulfate biosynthesis. Effects of 6-diazo-5-oxo-L-norleucine and low glutamine on the synthesis of heparan sulfate proteoglycan by human colon carcinoma cells.
Iozzo RV; Clark CC
J Biol Chem; 1987 Aug; 262(23):11188-99. PubMed ID: 2956263
[TBL] [Abstract][Full Text] [Related]
3. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Huber KR; Rosenfeld H; Roberts J
Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Escherichia coli glucosamine synthetase by novel electrophilic analogues of glutamine--comparison with 6-diazo-5-oxo-norleucine.
Walker B; Brown MF; Lynas JF; Martin SL; McDowell A; Badet B; Hill AJ
Bioorg Med Chem Lett; 2000 Dec; 10(24):2795-8. PubMed ID: 11133094
[TBL] [Abstract][Full Text] [Related]
5. Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro.
Greene RM; Kochhar DM
J Embryol Exp Morphol; 1975 Apr; 33(2):355-70. PubMed ID: 1176851
[TBL] [Abstract][Full Text] [Related]
6. Transport and membrane binding of the glutamine analogue 6-diazo-5-oxo-L-norleucine (DON) in Xenopus laevis oocytes.
Taylor PM; Mackenzie B; Hundal HS; Robertson E; Rennie MJ
J Membr Biol; 1992 Jun; 128(3):181-91. PubMed ID: 1501246
[TBL] [Abstract][Full Text] [Related]
7. The effects of 6-diazo-5-oxo-L-norleucine, a glutamine analogue, on the structure of the major cartilage proteoglycan synthesized by cultured chondrocytes.
Clark CC; Richards CF; Pacifici M; Iozzo RV
J Biol Chem; 1987 Jul; 262(21):10229-38. PubMed ID: 3112139
[TBL] [Abstract][Full Text] [Related]
8. Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
Wang SZ; Poore B; Alt J; Price A; Allen SJ; Hanaford AR; Kaur H; Orr BA; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
Clin Cancer Res; 2019 Oct; 25(19):5925-5936. PubMed ID: 31300448
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic studies of purine metabolism. V. Inhibition mechanism of diazo-oxo-norleucine in wild-type and in diazo-oxo-norleucine-resistant Escherichia coli.
TOMISEK AJ; REID MR
J Biol Chem; 1962 Mar; 237():807-11. PubMed ID: 13921756
[No Abstract] [Full Text] [Related]
10. Glucosamine synthetase from Escherichia coli: purification, properties, and glutamine-utilizing site location.
Badet B; Vermoote P; Haumont PY; Lederer F; LeGoffic F
Biochemistry; 1987 Apr; 26(7):1940-8. PubMed ID: 3297136
[TBL] [Abstract][Full Text] [Related]
11. Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry.
Alt J; Potter MC; Rojas C; Slusher BS
Anal Biochem; 2015 Apr; 474():28-34. PubMed ID: 25584882
[TBL] [Abstract][Full Text] [Related]
12. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
13. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
Aydelotte MB; Kochhar DM
Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
Kaufman ER
Somat Cell Mol Genet; 1985 Jan; 11(1):1-10. PubMed ID: 3856328
[TBL] [Abstract][Full Text] [Related]
15. The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia in vitro.
Griffiths M; Keast D; Patrick G; Crawford M; Palmer TN
Int J Biochem; 1993 Dec; 25(12):1749-55. PubMed ID: 8138012
[TBL] [Abstract][Full Text] [Related]
16. Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor.
Gao RD; Hin N; Prchalová E; Pal A; Lam J; Rais R; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2021 Oct; 50():128321. PubMed ID: 34400301
[TBL] [Abstract][Full Text] [Related]
17. Use of 6-diazo-5-oxo-L-norleucine to study interaction between myocardial glycoconjugate secretion and endothelial activation in the early embryonic chick heart.
Markwald RR; Funderburg FM
Dev Biol; 1983 Oct; 99(2):395-407. PubMed ID: 6618009
[TBL] [Abstract][Full Text] [Related]
18. Poliovirus and vesicular stomatitis virus replication in the presence of 6-diazo-5-oxo-L-norleucine or 2-deoxy-D-glucose.
Goldstein G; Guskey LE
J Med Virol; 1984; 14(2):159-67. PubMed ID: 6208320
[TBL] [Abstract][Full Text] [Related]
19. The rediscovery of DON (6-diazo-5-oxo-L-norleucine).
Kisner DL; Catane R; Muggia FM
Recent Results Cancer Res; 1980; 74():258-63. PubMed ID: 7192426
[TBL] [Abstract][Full Text] [Related]
20. Diazo-oxo-norleucine (DON)-induced alterations in the extracellular matrix of the mouse tooth germ.
Hurmerinta K; Thesleff I
Cell Differ; 1982 Apr; 11(2):107-13. PubMed ID: 7066992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
